Cardiometabolic RNAi Therapeutics Market

Key Players

  • Arrowhead Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Novartis
  • Eli Lilly
  • Silence Therapeutics
  • Amgen
  • Roche
  • Novo Nordisk
Future Market Insights

Cardiometabolic RNAi Therapeutics Market